Insilico Medicine announces the first deployment of its flagship generative chemistry AI platform for de novo molecular design, Chemistry42™ on Merck KGaA, Darmstadt, Germany’s high-performance computing infrastructure HONG KONG, Nov. 17, 2020 /PRNewswire/ — Following...
Read More
4 Minutes